col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Viruses
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines Yong Yang, Jinkai Zang, Shiqi Xu, Xueyang Zhang, Sule Yuan, Haikun Wang, et al. (+3)
2 [GO] 2021―Jul―23 The Emergence of SARS-CoV-2 within the Dog Population in Croatia: Host Factors and Clinical Outcome Vladimir Stevanovic, Irena Tabain, Tatjana Vilibic-Cavlek, Maja Mauric Maljkovic, Iva Benvin, Zeljka Hruskar, et al. (+20)
3 [GO] 2021―Jul―23 Virucidal Efficacy of Blue LED and Far-UVC Light Disinfection against Feline Infectious Peritonitis Virus as a Model for SARS-CoV-2 Amanda Gardner, Sayani Ghosh, Magdalena Dunowska, Gale Brightwell
4 [GO] 2021―Jul―23 SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, Maria Grazia Cusi
5 [GO] 2021―Jul―20 Viral Load and Patterns of SARS-CoV-2 Dissemination to the Lungs, Mediastinal Lymph Nodes, and Spleen of Patients with COVID-19 Associated Lymphopenia Adhamjon Abdullaev, Akmaljon Odilov, Maxim Ershler, Alexey Volkov, Tatiana Lipina, Tatiana Gasanova, et al. (+3)
6 [GO] 2021―Jul―20 Antiviral Effect of Budesonide against SARS-CoV-2 Natalie Heinen, Toni Luise Meister, Mara Klöhn, Eike Steinmann, Daniel Todt, Stephanie Pfaender
7 [GO] 2021―Jul―20 Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia Rowa Y. Alhabbab, Ahdab Alsaieedi, Abdullah Algaissi, Sara Almahboub, Rajaa M. Al-Raddadi, Omaima I. Shabouni, et al. (+11)
8 [GO] 2021―Jul―19 An Appraisal of the Current Scenario in Vaccine Research for COVID-19 Wai Chin Chong, Dinesh K. Chellappan, Shakti D. Shukla, Gregory M. Peterson, Rahul P. Patel, Niraj Kumar Jha, et al. (+4)
9 [GO] 2021―Jul―16 Cell Population Data and Serum Polyclonal Immunoglobulin Free Light Chains in the Assessment of COVID-19 Severity Milena Małecka-Giełdowska, Maria Fołta, Agnieszka Wiśniewska, Emilia Czyżewska, Olga Ciepiela
10 [GO] 2021―Jul―15 Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2 Julien Favresse, Constant Gillot, Laura Di Chiaro, Christine Eucher, Marc Elsen, Sandrine Van Eeckhoudt, et al. (+4)
11 [GO] 2021―Jul―15 First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain Sandra Barroso-Arévalo, Belén Rivera, Lucas Domínguez, José M. Sánchez-Vizcaíno
12 [GO] 2021―Jul―15 Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19 Henrik Berg Rasmussen, Gesche Jürgens, Ragnar Thomsen, Olivier Taboureau, Kornelius Zeth, Poul Erik Hansen, Peter Riis Hansen
13 [GO] 2021―Jul―14 Do Dogs and Cats Passively Carry SARS-CoV-2 on Hair and Pads? Stefania Lauzi, Angelica Stranieri, Alessia Giordano, Davide Lelli, Gabriella Elia, Costantina Desario, et al. (+3)
14 [GO] 2021―Jul―14 Human Coronaviruses Do Not Transfer Efficiently between Surfaces in the Absence of Organic Materials Matthew Dallner, Jennifer Harlow, Neda Nasheri
15 [GO] 2021―Jul―14 Variant Analysis of SARS-CoV-2 Genomes from Belgian Military Personnel Engaged in Overseas Missions and Operations Jean-Paul Pirnay, Philippe Selhorst, Samuel L. Hong, Christel Cochez, Barney Potter, Piet Maes, et al. (+20)
16 [GO] 2021―Jul―13 The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications Priya Veluswamy, Max Wacker, Dimitrios Stavridis, Thomas Reichel, Hendrik Schmidt, Maximilian Scherner, et al. (+2)
17 [GO] 2021―Jul―13 Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients Claudia Maria Trombetta, Serena Marchi, Simonetta Viviani, Alessandro Manenti, Linda Benincasa, Antonella Ruello, et al. (+4)
18 [GO] 2021―Jul―12 Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma, Berit Troost, Denise P.I. van de Pol, Heidi H. van der Ende-Metselaar, et al. (+8)
19 [GO] 2021―Jul―08 Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis Ahmad Shakeri, Natalia Konstantelos, Cherry Chu, Tony Antoniou, Jordan Feld, Katie J. Suda, Mina Tadrous
20 [GO] 2021―Jul―08 Comparison and Sensitivity Evaluation of Three Different Commercial Real-Time Quantitative PCR Kits for SARS-CoV-2 Detection Ana Banko, Gordana Petrovic, Danijela Miljanovic, Ana Loncar, Marija Vukcevic, Dragana Despot, Andja Cirkovic
21 [GO] 2021―Jul―07 Rationale and Criteria for a COVID-19 Model Framework Francesco Messina, Chiara Montaldo, Isabella Abbate, Manuela Antonioli, Veronica Bordoni, Giulia Matusali, et al. (+7)
22 [GO] 2021―Jul―05 Potential Prophylactic Treatments for COVID-19 Noam Ben-Zuk, Ido-David Dechtman, Itai Henn, Libby Weiss, Amichay Afriat, Esther Krasner, Yoav Gal
23 [GO] 2021―Jul―05 Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection Ivonne Melano, Li-Lan Kuo, Yan-Chung Lo, Po-Wei Sung, Ni Tien, Wen-Chi Su
24 [GO] 2021―Jul―05 From Protein to Pandemic: The Transdisciplinary Approach Needed to Prevent Spillover and the Next Pandemic Raina K. Plowright, Peter J. Hudson
25 [GO] 2021―Jul―01 Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders Maria de Lourdes Benamor Teixeira, Orlando da Costa Ferreira Júnior, Esaú João, Trevon Fuller, Juliana Silva Esteves, Wallace Mendes-Silva, et al. (+6)
26 [GO] 2021―Jun―30 COVID-19 Pandemic: Influence of Schools, Age Groups, and Virus Variants in Italy Giovanni Sebastiani, Giorgio Palé
27 [GO] 2021―Jun―30 Modular Evolution of Coronavirus Genomes Yulia Vakulenko, Andrei Deviatkin, Jan Felix Drexler, Alexander Lukashev
28 [GO] 2021―Jun―29 Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 Carla Zannella, Rosa Giugliano, Annalisa Chianese, Carmine Buonocore, Giovanni Andrea Vitale, Giuseppina Sanna, et al. (+8)
29 [GO] 2021―Jun―28 Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients Andrey A. Ivashchenko, Valeria N. Azarova, Alina N. Egorova, Ruben N. Karapetian, Dmitry V. Kravchenko, Natalia V. Krivonos, et al. (+9)
30 [GO] 2021―Jun―28 Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry Chuan Xu, Annie Wang, Mariana Marin, William Honnen, Santhamani Ramasamy, Edith Porter, et al. (+5)
31 [GO] 2021―Jun―28 Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil Cassia F. Estofolete, Cecilia A. Banho, Guilherme R. F. Campos, Beatriz de C. Marques, Livia Sacchetto, Leila S. Ullmann, et al. (+10)
32 [GO] 2021―Jun―28 Emodin from Aloe Inhibits Porcine Reproductive and Respiratory Syndrome Virus via Toll-Like Receptor 3 Activation Zhichao Xu, Meiyan Huang, Yongbo Xia, Peng Peng, Yun Zhang, Shumei Zheng, et al. (+3)
33 [GO] 2021―Jun―25 The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2 Mya Myat Ngwe Tun, Kouichi Morita, Takeshi Ishikawa, Shuzo Urata
34 [GO] 2021―Jun―25 Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations Mahendra Rai, Shital Bonde, Alka Yadav, Arpita Bhowmik, Sanjay Rathod, Pramod Ingle, Aniket Gade
35 [GO] 2021―Jun―25 Coronaviruses in Bats: A Review for the Americas Itandehui Hernández-Aguilar, Consuelo Lorenzo, Antonio Santos-Moreno, Eduardo J. Naranjo, Darío Navarrete-Gutiérrez
36 [GO] 2021―Jun―25 A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner Yu-Min Choi, Hyein Jeong, Uni Park, Nam-Hyuk Cho, Bum-Joon Kim
37 [GO] 2021―Jun―24 Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail Arnaud C. Drouin, Marc W. Theberge, Sharon Y. Liu, Allison R. Smither, Shelby M. Flaherty, Mark Zeller, et al. (+11)
38 [GO] 2021―Jun―24 SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies Daniele Focosi, Marco Tuccori, Andreina Baj, Fabrizio Maggi
39 [GO] 2021―Jun―23 Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review Massimo Franchini, Federico Prefumo, Gianpaolo Grisolia, Valentino Bergamini, Claudia Glingani, Marlene Pisello, et al. (+2)
40 [GO] 2021―Jun―23 Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Ivana Lazarevic, Vera Pravica, Danijela Miljanovic, Maja Cupic
41 [GO] 2021―Jun―23 SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, Hedvig Nordeng, Eva Gerbier, Valentine Lambelet, et al. (+5)
42 [GO] 2021―Jun―17 Impact of COVID-19 Mitigation Measures on Mosquito-Borne Diseases in 2020 in Queensland, Australia Cassie C. Jansen, Jonathan M. Darbro, Frances A. Birrell, Martin A. Shivas, Andrew F. van den Hurk
43 [GO] 2021―Jun―17 Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2 Mateusz Dróżdż, Paweł Krzyżek, Barbara Dudek, Sebastian Makuch, Adriana Janczura, Emil Paluch
44 [GO] 2021―Jun―16 Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies Hakimeh Baghaei Daemi, Muhammad Fakhar-e-Alam Kulyar, Xinlin He, Chengfei Li, Morteza Karimpour, Xiaomei Sun, et al. (+2)
45 [GO] 2021―Jun―15 Functions of Coronavirus Accessory Proteins: Overview of the State of the Art Puxian Fang, Liurong Fang, Huichang Zhang, Sijin Xia, Shaobo Xiao
46 [GO] 2021―Jun―15 SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study Konstantinos Belogiannis, Venetia A. Florou, Paraskevi C. Fragkou, Stefanos Ferous, Loukas Chatzis, Aikaterini Polyzou, et al. (+7)
47 [GO] 2021―Jun―15 Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera Natalia Kruglova, Andrei Siniavin, Vladimir Gushchin, Dmitriy Mazurov
48 [GO] 2021―Jun―15 Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments Mehrshad Sadria, Anita T. Layton
49 [GO] 2021―Jun―15 Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals Benjamin Trinité, Edwards Pradenas, Silvia Marfil, Carla Rovirosa, Víctor Urrea, Ferran Tarrés-Freixas, et al. (+21)
50 [GO] 2021―Jun―15 Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism Wataru Nishima, Marta Kulik
51 [GO] 2021―Jun―11 Field and Molecular Epidemiology: How Viral Sequencing Changed Transmission Inferences in the First Portuguese SARS-CoV-2 Infection Cluster Nicole Pedro, Veronica Fernandes, Bruno Cavadas, João Tiago Guimarães, Henrique Barros, Margarida Tavares, Luisa Pereira
52 [GO] 2021―Jun―11 Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020 Ralf Wagner, David Peterhoff, Stephanie Beileke, Felix Günther, Melanie Berr, Sebastian Einhauser, et al. (+17)
53 [GO] 2021―Jun―10 The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation Zhihua Bai, Ying Cao, Wenjun Liu, Jing Li
54 [GO] 2021―Jun―09 A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic Andreas C. Chrysostomou, Bram Vrancken, George Koumbaris, George Themistokleous, Antonia Aristokleous, Christina Masia, et al. (+11)
55 [GO] 2021―Jun―08 Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity Mackenzie E. Coden, Lucas F. Loffredo, Hiam Abdala-Valencia, Sergejs Berdnikovs
56 [GO] 2021―Jun―08 Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene Alyssa T. Pyke, Neelima Nair, Andrew F. van den Hurk, Peter Burtonclay, Son Nguyen, Jean Barcelon, et al. (+4)
57 [GO] 2021―Jun―07 Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France Anne Gégout Petit, Hélène Jeulin, Karine Legrand, Nicolas Jay, Agathe Bochnakian, Pierre Vallois, et al. (+2)
58 [GO] 2021―Jun―07 Characterization of Winter Dysentery Bovine Coronavirus Isolated from Cattle in Israel Dan David, Nick Storm, Waksman Ilan, Asaf Sol
59 [GO] 2021―Jun―04 Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome Oleksandr Oliynyk, Wojciech Barg, Anna Slifirczyk, Yanina Oliynyk, Vitaliy Gurianov, Marta Rorat
60 [GO] 2021―Jun―04 Effective Communication at Different Phases of COVID-19 Prevention: Roles, Enablers and Barriers Khayriyyah Mohd Hanafiah, Celine Ng, Abdul Matiin Wan
61 [GO] 2021―Jun―04 Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy Gitana Scozzari, Cristina Costa, Enrica Migliore, Maurizio Coggiola, Giovannino Ciccone, Luigi Savio, et al. (+5)
62 [GO] 2021―Jun―04 The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner Victoria Callahan, Seth Hawks, Matthew A. Crawford, Caitlin W. Lehman, Holly A. Morrison, Hannah M. Ivester, et al. (+9)
63 [GO] 2021―Jun―03 A Bioluminescent Biosensor for Quantifying the Interaction of SARS-CoV-2 and Its Receptor ACE2 in Cells and In Vitro Xiaolong Yang, Lidong Liu, Yawei Hao, Eva So, Sahar Sarmasti Emami, Derek Zhang, et al. (+3)
64 [GO] 2021―Jun―02 DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination Gerardo Casucci, Domenico Acanfora
65 [GO] 2021―Jun―01 Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2 Tove Hoffman, Linda Kolstad, Bengt Rönnberg, Åke Lundkvist
66 [GO] 2021―Jun―01 Evolutionary Patterns of Codon Usage in Major Lineages of Porcine Reproductive and Respiratory Syndrome Virus in China Weixin Wu, Xinna Ge, Yongning Zhang, Jun Han, Xin Guo, Lei Zhou, Hanchun Yang
67 [GO] 2021―May―31 COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation Abby C. Lee, Grant Castaneda, Wei Tse Li, Chengyu Chen, Neil Shende, Jaideep Chakladar, et al. (+3)
68 [GO] 2021―May―31 Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations Anna Gladkikh, Anna Dolgova, Vladimir Dedkov, Valeriya Sbarzaglia, Olga Kanaeva, Anna Popova, Areg Totolian
69 [GO] 2021―May―31 Insights into SARS-CoV-2 Persistence and Its Relevance Belete A. Desimmie, Yonas Y. Raru, Hesham M. Awadh, Peimei He, Samson Teka, Kara S. Willenburg
70 [GO] 2021―May―31 Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management Martina Brandolini, Francesca Taddei, Maria Michela Marino, Laura Grumiro, Agata Scalcione, Maria Elena Turba, et al. (+5)
71 [GO] 2021―May―28 The Spike of Concern-The Novel Variants of SARS-CoV-2 Anna Winger, Thomas Caspari
72 [GO] 2021―May―28 The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany Anna Michelitsch, Jacob Schön, Donata Hoffmann, Martin Beer, Kerstin Wernike
73 [GO] 2021―May―28 Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis P. Brito-Zerón, B. Gracia-Tello, A. Robles, A. Alguacil, M. Bonet, B. De-Escalante, et al. (+6)
74 [GO] 2021―May―27 Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays Jenni Virtanen, Ruut Uusitalo, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura, Suvi Kuivanen, et al. (+11)
75 [GO] 2021―May―27 Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2 Tove Hoffman, Linda Kolstad, Johanna F. Lindahl, Bo Albinsson, Anders Bergqvist, Bengt Rönnberg, Åke Lundkvist
76 [GO] 2021―May―27 Is the First of the Two Born Saved? A Rare and Dramatic Case of Double Placental Damage from SARS-CoV-2 Leonardo Resta, Antonella Vimercati, Sara Sablone, Andrea Marzullo, Gerardo Cazzato, Giuseppe Ingravallo, et al. (+4)
77 [GO] 2021―May―27 Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon Ali A. Samaha, Hussein Mouawia, Mirna Fawaz, Hamad Hassan, Ali Salami, Ali Al Bazzal, et al. (+10)
78 [GO] 2021―May―27 Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil Filipe R. R. Moreira, Diego M. Bonfim, Danielle A. G. Zauli, Joice P. Silva, Aline B. Lima, Frederico S. V. Malta, et al. (+12)
79 [GO] 2021―May―26 Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2 Christina Chuong, Christine M. DuChane, Emily M. Webb, Pallavi Rai, Jeffrey M. Marano, Chad M. Bernier, et al. (+2)
80 [GO] 2021―May―25 Identification of Novel Candidate CD8+ T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses Pradeep Darshana Pushpakumara, Deshan Madhusanka, Saubhagya Dhanasekara, Chandima Jeewandara, Graham S. Ogg, Gathsaurie Neelika Malavige
81 [GO] 2021―May―24 Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19 Maria Laura De Angelis, Federica Francescangeli, Rachele Rossi, Alessandro Giuliani, Ruggero De Maria, Ann Zeuner
82 [GO] 2021―May―24 Dysregulation of Pulmonary Responses in Severe COVID-19 Dandan Wu, Xuexian O. Yang
83 [GO] 2021―May―24 Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned Lars Dölken, August Stich, Christoph D. Spinner
84 [GO] 2021―May―24 GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice Jide Tian, Blake Middleton, Daniel L. Kaufman
85 [GO] 2021―May―24 Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay Davor Brinc, Mia J. Biondi, Daniel Li, Heng Sun, Camelia Capraru, David Smookler, et al. (+4)
86 [GO] 2021―May―24 Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms Chuan Xu, Annie Wang, Ke Geng, William Honnen, Xuening Wang, Natalie Bruiners, et al. (+8)
87 [GO] 2021―May―20 Optimization and Clinical Evaluation of a Multi-Target Loop-Mediated Isothermal Amplification Assay for the Detection of SARS-CoV-2 in Nasopharyngeal Samples Foteini Roumani, Sarah Azinheiro, Hugo Sousa, Ana Sousa, Mafalda Timóteo, Tatiana Varandas, et al. (+5)
88 [GO] 2021―May―20 SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA Sarah A. Hamer, Alex Pauvolid-Corrêa, Italo B. Zecca, Edward Davila, Lisa D. Auckland, Christopher M. Roundy, et al. (+11)
89 [GO] 2021―May―20 SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein Ryosuke Matsuura, Chieh-Wen Lo, Satoshi Wada, Junichi Somei, Heihachiro Ochiai, Takeharu Murakami, et al. (+7)
90 [GO] 2021―May―19 Overview of Bat and Wildlife Coronavirus Surveillance in Africa: A Framework for Global Investigations Marike Geldenhuys, Marinda Mortlock, Jonathan H. Epstein, Janusz T. Pawęska, Jacqueline Weyer, Wanda Markotter
91 [GO] 2021―May―19 Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro Fabrizio Pucci, Marianne Rooman
92 [GO] 2021―May―18 A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis Carmen María González-Domenech, Isabel Pérez-Hernández, Cristina Gómez-Ayerbe, Isabel Viciana Ramos, Rosario Palacios-Muñoz, Jesús Santos
93 [GO] 2021―May―17 Social Restrictions versus Testing Campaigns in the COVID-19 Crisis: A Predictive Model Based on the Spanish Case Francisco Javier Candel, Elisabet Viayna, Daniel Callejo, Raul Ramos, Jesús San-Roman-Montero, Pablo Barreiro, et al. (+5)
94 [GO] 2021―May―17 An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India Pragya D. Yadav, Dimpal A. Nyayanit, Triparna Majumdar, Savita Patil, Harmanmeet Kaur, Nivedita Gupta, et al. (+42)
95 [GO] 2021―May―17 Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2 Kien Nguyen, Srirupa Chakraborty, Rachael A. Mansbach, Bette Korber, Sandrasegaram Gnanakaran
96 [GO] 2021―May―17 Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity Hengsheng Fang, Adam D. Wegman, Kianna Ripich, Heather Friberg, Jeffrey R. Currier, Stephen J. Thomas, et al. (+2)
97 [GO] 2021―May―17 Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2 Miray Tonk, Daniel Růžek, Andreas Vilcinskas
98 [GO] 2021―May―17 Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America Elena Quinonez, Majid Vahed, Abdolrazagh Hashemi Shahraki, Mehdi Mirsaeidi
99 [GO] 2021―May―17 Diagnostic Performance of Ag-RDTs and NAAT for SARS-CoV2 Identification in Symptomatic Patients in Catalonia Luca Basile, Víctor Guadalupe-Fernández, Manuel Valdivia Guijarro, Ana Martinez Mateo, Pilar Ciruela Navas, Jacobo Mendioroz Peña
100 [GO] 2021―May―14 Critical Aspects Concerning the Development of a Pooling Approach for SARS-CoV-2 Diagnosis Using Large-Scale PCR Testing Daniel Cruceriu, Oana Baldasici, Loredana Balacescu, Stefana Gligor-Popa, Mirela Flonta, Milena A. Man, et al. (+5)
101 [GO] 2021―May―13 Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples Richard S. Bennett, Elena N. Postnikova, Janie Liang, Robin Gross, Steven Mazur, Saurabh Dixit, et al. (+8)
102 [GO] 2021―May―13 Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2 Chloé Dimeglio, Marine Milhes, Jean-Michel Loubes, Noémie Ranger, Jean-Michel Mansuy, Pauline Trémeaux, et al. (+5)
103 [GO] 2021―May―13 SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment Michel Drancourt, Sébastien Cortaredona, Cléa Melenotte, Sophie Amrane, Carole Eldin, Bernard La Scola, et al. (+5)
104 [GO] 2021―May―13 Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing Daniela Loconsole, Anna Sallustio, Marisa Accogli, Francesca Centrone, Daniele Casulli, Antonino Madaro, et al. (+3)
105 [GO] 2021―May―13 Cascading from SARS-CoV-2 to Parkinson’s Disease through Protein-Protein Interactions Ernesto Estrada
106 [GO] 2021―May―13 Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2 Florence Carrouel, Martine Valette, Hervé Perrier, Maude Bouscambert-Duchamp, Claude Dussart, Paul Tramini, Denis Bourgeois
107 [GO] 2021―May―12 Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19 Yesha H. Parekh, Nicole J. Altomare, Erin P. McDonnell, Martin J. Blaser, Payal D. Parikh
108 [GO] 2021―May―12 Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike’s Dynamics Jorge González-Puelma, Jacqueline Aldridge, Marco Montes de Oca, Mónica Pinto, Roberto Uribe-Paredes, José Fernández-Goycoolea, et al. (+8)
109 [GO] 2021―May―12 Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity Elżbieta Rutkowska, Iwona Kwiecień, Magdalena Żabicka, Artur Maliborski, Agata Raniszewska, Krzysztof Kłos, et al. (+4)
110 [GO] 2021―May―10 Virological Correlates of IgM-IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens Pablo Barreiro, Francisco Javier Candel, Juan Carlos Sanz, Jesús San Román, María del Mar Carretero, Marta Pérez-Abeledo, et al. (+5)
111 [GO] 2021―May―10 The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro Raphael J. Eberle, Danilo S. Olivier, Marcos S. Amaral, Ian Gering, Dieter Willbold, Raghuvir K. Arni, Monika A. Coronado
112 [GO] 2021―May―08 Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective Saly Kanj, Basem Al-Omari
113 [GO] 2021―May―08 Clinical and Radiological Profiles of COVID-19 Patients with Neurological Symptomatology: A Comparative Study Maria de Fatima Viana Vasco Aragao, Mariana de Carvalho Leal, Pedro Henrique Pereira Andrade, Ocelio Queiroga Cartaxo Filho, Lucas Vasco Aragao, Tatiana Moreira Fonseca, et al. (+7)
114 [GO] 2021―May―08 Will SARS-CoV-2 Become Just Another Seasonal Coronavirus? Alexander B. Beams, Rebecca Bateman, Frederick R. Adler
115 [GO] 2021―May―08 Identification of SARS-CoV-2 and Enteroviruses in Sewage Water-A Pilot Study Anda Băicuș, Carmen Maria Cherciu, Mihaela Lazăr
116 [GO] 2021―May―08 Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study Sara Cruz Melguizo, María Luisa de la Cruz Conty, Paola Carmona Payán, Alejandra Abascal-Saiz, Pilar Pintando Recarte, Laura González Rodríguez, et al. (+14)
117 [GO] 2021―May―06 Clinical Characteristics and Outcomes of COVID-19 in West Virginia Sijin Wen, Apoorv Prasad, Kerri Freeland, Sanjiti Podury, Jenil Patel, Roshan Subedi, et al. (+5)
118 [GO] 2021―May―02 Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Sheng-Teng Huang, Yeh Chen, Wei-Chao Chang, Hsiao-Fan Chen, Hsiang-Chun Lai, Yu-Chun Lin, et al. (+5)
119 [GO] 2021―May―02 Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR? Valeria Cento, Silvia Renica, Elisa Matarazzo, Maria Antonello, Luna Colagrossi, Federica Di Ruscio, et al. (+7)
120 [GO] 2021―Apr―30 Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody™ COVAG025) for COVID-19 Diagnosis Doyeong Kim, Jihoo Lee, Jyotiranjan Bal, Seul Ki Seo, Chom-Kyu Chong, Jong Ho Lee, Hyun Park
121 [GO] 2021―Apr―30 Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country Jiwon Jung, Jinyeong Kim, Joon Seo Lim, Eun Ok Kim, Mi-Na Kim, Sung-Han Kim
122 [GO] 2021―Apr―30 Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis Jana Suklan, James Cheaveau, Sarah Hill, Samuel G. Urwin, Kile Green, Amanda Winter, et al. (+7)
123 [GO] 2021―Apr―30 Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2 Sreejith Rajasekharan, Rafaela Milan Bonotto, Lais Nascimento Alves, Yvette Kazungu, Monica Poggianella, Pamela Martinez-Orellana, et al. (+3)
124 [GO] 2021―Apr―30 Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis Fanni Dembrovszky, Szilárd Váncsa, Nelli Farkas, Bálint Erőss, Lajos Szakó, Brigitta Teutsch, et al. (+8)
125 [GO] 2021―Apr―30 Fast Detection of SARS-CoV-2 RNA Directly from Respiratory Samples Using a Loop-Mediated Isothermal Amplification (LAMP) Test Olympia E. Anastasiou, Caroline Holtkamp, Miriam Schäfer, Frieda Schön, Anna Maria Eis-Hübinger, Andi Krumbholz
126 [GO] 2021―Apr―29 Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort Muneerah Smith, Houari B. Abdesselem, Michelle Mullins, Ti-Myen Tan, Andrew J. M. Nel, Maryam A. Y. Al-Nesf, et al. (+21)
127 [GO] 2021―Apr―29 Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach Yasmin Hisham, Yaqoub Ashhab, Sang-Hyun Hwang, Dong-Eun Kim
128 [GO] 2021―Apr―29 Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales Philippe Colson, Didier Raoult
129 [GO] 2021―Apr―29 Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy Francesca Di Giallonardo, Ilaria Puglia, Valentina Curini, Cesare Cammà, Iolanda Mangone, Paolo Calistri, et al. (+3)
130 [GO] 2021―Apr―29 In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease Natalie Heinen, Mara Klöhn, Eike Steinmann, Stephanie Pfaender
131 [GO] 2021―Apr―28 The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment Igor Kudryavtsev, Olga Kalinina, Vadim Bezrukikh, Olesya Melnik, Alexey Golovkin
132 [GO] 2021―Apr―27 D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients Benjamin Thoreau, Joris Galland, Maxime Delrue, Marie Neuwirth, Alain Stepanian, Anthony Chauvin, et al. (+28)
133 [GO] 2021―Apr―27 Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings? Shirley Masse, Camille Bonnet, Ana-Maria Vilcu, Hayat Benamar, Morgane Swital, Sylvie van der Werf, et al. (+4)
134 [GO] 2021―Apr―27 Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences Bohu Pan, Zuowei Ji, Sugunadevi Sakkiah, Wenjing Guo, Jie Liu, Tucker A. Patterson, Huixiao Hong
135 [GO] 2021―Apr―26 Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech) Johannes Korth, Michael Jahn, Oliver Dorsch, Olympia Evdoxia Anastasiou, Burkhard Sorge-Hädicke, Ute Eisenberger, et al. (+6)
136 [GO] 2021―Apr―26 Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant’s Source Karin Moelling
137 [GO] 2021―Apr―25 From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome Julia Butt, Rajagopal Murugan, Theresa Hippchen, Sylvia Olberg, Monique van Straaten, Hedda Wardemann, et al. (+9)
138 [GO] 2021―Apr―25 Accessible LAMP-Enabled Rapid Test (ALERT) for Detecting SARS-CoV-2 Ali Bektaş, Michael F. Covington, Guy Aidelberg, Anibal Arce, Tamara Matute, Isaac Núñez, et al. (+6)
139 [GO] 2021―Apr―25 A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection Dung Nguyen, Donal Skelly, Niluka Goonawardane
140 [GO] 2021―Apr―23 Genomic Surveillance of Circulating SARS-CoV-2 in South East Italy: A One-Year Retrospective Genetic Study Loredana Capozzi, Angelica Bianco, Laura Del Sambro, Domenico Simone, Antonio Lippolis, Maria Notarnicola, et al. (+4)
141 [GO] 2021―Apr―23 Superiority of MALDI-TOF Mass Spectrometry over Real-Time PCR for SARS-CoV-2 RNA Detection Magda Rybicka, Ewa Miłosz, Krzysztof Piotr Bielawski
142 [GO] 2021―Apr―22 SARS-CoV-2 and Placenta: New Insights and Perspectives Leonardo Resta, Antonella Vimercati, Gerardo Cazzato, Giulia Mazzia, Ettore Cicinelli, Anna Colagrande, et al. (+4)
143 [GO] 2021―Apr―22 A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil Paola Cristina Resende, Tiago Gräf, Anna Carolina Dias Paixão, Luciana Appolinario, Renata Serrano Lopes, Ana Carolina da Fonseca Mendonça, et al. (+26)
144 [GO] 2021―Apr―21 Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies Joe James, Shelley Rhodes, Craig S. Ross, Paul Skinner, Samuel P. Smith, Rebecca Shipley, et al. (+10)
145 [GO] 2021―Apr―20 When the COVID-19 Pandemic Surges during Influenza Season: Lessons Learnt from the Sentinel Laboratory-Based Surveillance of Influenza-Like Illness in Lombardy during the 2019-2020 Season Cristina Galli, Laura Pellegrinelli, Laura Bubba, Valeria Primache, Giovanni Anselmi, Serena Delbue, et al. (+5)
146 [GO] 2021―Apr―20 Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects Angela Huynh, Donald M. Arnold, James W. Smith, Jane C. Moore, Ali Zhang, Zain Chagla, et al. (+10)
147 [GO] 2021―Apr―20 Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE Su Datt Lam, Paul Ashford, Sandra Díaz-Sánchez, Margarita Villar, Christian Gortázar, José de la Fuente, Christine Orengo
148 [GO] 2021―Apr―16 Genetic Characterisation and Comparison of Three Human Coronaviruses (HKU1, OC43, 229E) from Patients and Bovine Coronavirus (BCoV) from Cattle with Respiratory Disease in Slovenia Monika Jevšnik Virant, Danijela Černe, Miroslav Petrovec, Tomislav Paller, Ivan Toplak
149 [GO] 2021―Apr―16 Five Antigen Tests for SARS-CoV-2: Virus Viability Matters Miroslav Homza, Hana Zelena, Jaroslav Janosek, Hana Tomaskova, Eduard Jezo, Alena Kloudova, et al. (+3)
150 [GO] 2021―Apr―14 Household Cases Suggest That Cats Belonging to Owners with COVID-19 Have a Limited Role in Virus Transmission Pierre Bessière, Maxime Fusade-Boyer, Mathilda Walch, Laetitia Lèbre, Jessie Brun, Guillaume Croville, et al. (+3)
151 [GO] 2021―Apr―14 Transcriptional Landscape of Vero E6 Cells during Early Swine Acute Diarrhea Syndrome Coronavirus Infection Siying Zeng, Ouyang Peng, Ruipu Sun, Qiuping Xu, Fangyu Hu, Yan Zhao, et al. (+3)
152 [GO] 2021―Apr―13 Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19 Meehyun Ko, So Young Chang, Soo Young Byun, Aleksandr Ianevski, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, et al. (+7)
153 [GO] 2021―Apr―13 Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro Gunsup Lee, Shailesh Budhathoki, Geum-Young Lee, Kwang-ji Oh, Yeon Kyoung Ham, Young-Jun Kim, et al. (+10)
154 [GO] 2021―Apr―13 Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2 Maximilian Große, Natalia Ruetalo, Mirjam Layer, Dan Hu, Ramona Businger, Sascha Rheber, et al. (+7)
155 [GO] 2021―Apr―13 Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2 Florian Hitzenbichler, Stilla Bauernfeind, Bernd Salzberger, Barbara Schmidt, Jürgen J. Wenzel
156 [GO] 2021―Apr―13 The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells Eun Jeong Park, Phyoe Kyawe Myint, Michael Gyasi Appiah, Samuel Darkwah, Siqingaowa Caidengbate, Atsushi Ito, et al. (+4)
157 [GO] 2021―Apr―13 The Photosensitizer Octakis(cholinyl)zinc Phthalocyanine with Ability to Bind to a Model Spike Protein Leads to a Loss of SARS-CoV-2 Infectivity In Vitro When Exposed to Far-Red LED Kirill Sharshov, Mariya Solomatina, Olga Kurskaya, Ilya Kovalenko, Ekaterina Kholina, Vladimir Fedorov, et al. (+3)
158 [GO] 2021―Apr―13 SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies Thomas Theo Brehm, Susanne Pfefferle, Ronald von Possel, Robin Kobbe, Dominik Nörz, Stefan Schmiedel, et al. (+14)
159 [GO] 2021―Apr―13 SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus Giulia Matusali, Francesca Colavita, Daniele Lapa, Silvia Meschi, Licia Bordi, Pierluca Piselli, et al. (+7)
160 [GO] 2021―Apr―09 Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2 Shi Zhao, Jingzhi Lou, Marc K. C. Chong, Lirong Cao, Hong Zheng, Zigui Chen, et al. (+4)
161 [GO] 2021―Apr―09 Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters Lisa Allnoch, Georg Beythien, Eva Leitzen, Kathrin Becker, Franz-Josef Kaup, Stephanie Stanelle-Bertram, et al. (+7)
162 [GO] 2021―Apr―09 Mitigating Future Respiratory Virus Pandemics: New Threats and Approaches to Consider Gregory C. Gray, Emily R. Robie, Caleb J. Studstill, Charles L. Nunn
163 [GO] 2021―Apr―08 The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus Yeong Jun Kim, Ui Soon Jang, Sandrine M. Soh, Joo-Youn Lee, Hye-Ra Lee
164 [GO] 2021―Apr―07 Neutralizing Antibody Therapeutics for COVID-19 Aeron C. Hurt, Adam K. Wheatley
165 [GO] 2021―Apr―04 A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy Eva Spada, Fabrizio Vitale, Federica Bruno, Germano Castelli, Stefano Reale, Roberta Perego, et al. (+2)
166 [GO] 2021―Apr―02 Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2 Julia Werner, Raphael M. Kronberg, Pawel Stachura, Philipp N. Ostermann, Lisa Müller, Heiner Schaal, et al. (+6)
167 [GO] 2021―Apr―02 FIB-SEM as a Volume Electron Microscopy Approach to Study Cellular Architectures in SARS-CoV-2 and Other Viral Infections: A Practical Primer for a Virologist Valentina Baena, Ryan Conrad, Patrick Friday, Ella Fitzgerald, Taeeun Kim, John Bernbaum, et al. (+4)
168 [GO] 2021―Apr―02 Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease Lukas van de Sand, Maren Bormann, Mira Alt, Leonie Schipper, Christiane Silke Heilingloh, Eike Steinmann, et al. (+5)
169 [GO] 2021―Apr―02 Evaluation of an Automated High-Throughput Liquid-Based RNA Extraction Platform on Pooled Nasopharyngeal or Saliva Specimens for SARS-CoV-2 RT-PCR Allen Wing-Ho Chu, Cyril Chik-Yan Yip, Wan-Mui Chan, Anthony Chin-Ki Ng, Dream Lok-Sze Chan, Ryan Ho-Ping Siu, et al. (+7)
170 [GO] 2021―Apr―01 Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera Myndi G. Holbrook, Simon J. Anthony, Isamara Navarrete-Macias, Theo Bestebroer, Vincent J. Munster, Neeltje van Doremalen
171 [GO] 2021―Apr―01 Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes Maren Bormann, Mira Alt, Leonie Schipper, Lukas van de Sand, Mona Otte, Toni Luise Meister, et al. (+4)
172 [GO] 2021―Apr―01 Nosocomial Outbreak of SARS-CoV-2 in a “non-COVID-19” Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission Vítor Borges, Joana Isidro, Filipe Macedo, José Neves, Luís Silva, Mário Paiva, et al. (+7)
173 [GO] 2021―Mar―31 Limited Genetic Diversity Detected in Middle East Respiratory Syndrome-Related Coronavirus Variants Circulating in Dromedary Camels in Jordan Stephanie N. Seifert, Jonathan E. Schulz, Stacy Ricklefs, Michael Letko, Elangeni Yabba, Zaidoun S. Hijazeen, et al. (+14)
174 [GO] 2021―Mar―31 IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection Aurora Pérez, Isidro Torregrosa, Luis D’Marco, Isabel Juan, Liria Terradez, Miguel Ángel Solís, et al. (+4)
175 [GO] 2021―Mar―29 Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2? Jean-Nicolas Tournier, Joseph Kononchik
176 [GO] 2021―Mar―29 A Strong Seasonality Pattern for Covid-19 Incidence Rates Modulated by UV Radiation Levels Christos Karapiperis, Panos Kouklis, Stelios Papastratos, Anastasia Chasapi, Antoine Danchin, Lefteris Angelis, Christos A. Ouzounis
177 [GO] 2021―Mar―26 Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes Alessio Lorusso, Paolo Calistri, Giovanni Savini, Daniela Morelli, Lucio Ambrosij, Giacomo Migliorati, Nicola D’Alterio
178 [GO] 2021―Mar―26 Adjusting the Cut-Off and Maximum Pool Size in RT-qPCR Pool Testing for SARS-CoV-2 Murilo S. Costa, Hugo I. Sato, Raissa P. Rocha, Alex F. Carvalho, Nathalia S. Guimarães, Elaine L. Machado, et al. (+5)
179 [GO] 2021―Mar―26 Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells Ieva Bagdonaite, Andrew J. Thompson, Xiaoning Wang, Max Søgaard, Cyrielle Fougeroux, Martin Frank, et al. (+6)
180 [GO] 2021―Mar―26 Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure Emma K. Loveday, Kyle S. Hain, Irina Kochetkova, Jodi F. Hedges, Amanda Robison, Deann T. Snyder, et al. (+5)
181 [GO] 2021―Mar―26 In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2 Pantea Kiani, Andrew Scholey, Thomas A. Dahl, Lauren McMann, Jacqueline M. Iversen, Joris C. Verster
182 [GO] 2021―Mar―25 NSP16 2′-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies Li-Jen Chang, Tsung-Hsien Chen
183 [GO] 2021―Mar―25 Amantadine Inhibits SARS-CoV-2 In Vitro Klaus Fink, Andreas Nitsche, Markus Neumann, Marica Grossegesse, Karl-Heinz Eisele, Wojciech Danysz
184 [GO] 2021―Mar―25 Key Factors That Enable the Pandemic Potential of RNA Viruses and Inter-Species Transmission: A Systematic Review Santiago Alvarez-Munoz, Nicolas Upegui-Porras, Arlen P. Gomez, Gloria Ramirez-Nieto
185 [GO] 2021―Mar―24 SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma Julia Klaus, Carlo Palizzotto, Eric Zini, Marina L. Meli, Chiara Leo, Herman Egberink, et al. (+2)
186 [GO] 2021―Mar―24 Light Sheet Microscopy-Assisted 3D Analysis of SARS-CoV-2 Infection in the Respiratory Tract of the Ferret Model Luca M. Zaeck, David Scheibner, Julia Sehl, Martin Müller, Donata Hoffmann, Martin Beer, et al. (+4)
187 [GO] 2021―Mar―24 Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses Sabina Andreu, Inés Ripa, Raquel Bello-Morales, José Antonio López-Guerrero
188 [GO] 2021―Mar―24 Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin
189 [GO] 2021―Mar―22 Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods Denise Utami Putri, Cheng-Hui Wang, Po-Chun Tseng, Wen-Sen Lee, Fu-Lun Chen, Han-Pin Kuo, et al. (+2)
190 [GO] 2021―Mar―22 The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score Michele Ghidini, Alice Indini, Erika Rijavec, Claudia Bareggi, Monica Cattaneo, Gianluca Tomasello, et al. (+3)
191 [GO] 2021―Mar―22 Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases Szilárd Váncsa, Fanni Dembrovszky, Nelli Farkas, Lajos Szakó, Brigitta Teutsch, Stefania Bunduc, et al. (+5)
192 [GO] 2021―Mar―22 Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans Shuyi Yang, Keith R. Jerome, Alexander L. Greninger, Joshua T. Schiffer, Ashish Goyal
193 [GO] 2021―Mar―22 Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa Susan Engelbrecht, Kayla Delaney, Bronwyn Kleinhans, Eduan Wilkinson, Houriiyah Tegally, Tania Stander, et al. (+3)
194 [GO] 2021―Mar―19 Treatment Protocol for COVID-19 Based on T2R Phenotype Mohamed A. Taha, Christian A. Hall, Colin J. Shortess, Richard F. Rathbone, Henry P. Barham
195 [GO] 2021―Mar―18 Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland Julia Klaus, Marina Meli, Barbara Willi, Sarah Nadeau, Christian Beisel, Tanja Stadler, et al. (+8)
196 [GO] 2021―Mar―18 SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zonosis and Models for Study Tessa Prince, Shirley L. Smith, Alan D. Radford, Tom Solomon, Grant L. Hughes, Edward I. Patterson
197 [GO] 2021―Mar―18 COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond Bashair M. Mussa, Ankita Srivastava, Anthony J. M. Verberne
198 [GO] 2021―Mar―12 Quantification of the Tradeoff between Test Sensitivity and Test Frequency in a COVID-19 Epidemic-A Multi-Scale Modeling Approach Jonathan E. Forde, Stanca M. Ciupe
199 [GO] 2021―Mar―12 Spatiotemporal Analysis of COVID-19 Incidence Data Ilaria Spassiani, Giovanni Sebastiani, Giorgio Palé
200 [GO] 2021―Mar―12 Pulsed Broad-Spectrum UV Light Effectively Inactivates SARS-CoV-2 on Multiple Surfaces and N95 Material Alexander S. Jureka, Caroline G. Williams, Christopher F. Basler
201 [GO] 2021―Mar―11 A Comparative Systematic Review of COVID-19 and Influenza Molka Osman, Timothée Klopfenstein, Nabil Belfeki, Vincent Gendrin, Souheil Zayet
202 [GO] 2021―Mar―11 Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology Gennady Sukhikh, Ulyana Petrova, Andrey Prikhodko, Natalia Starodubtseva, Konstantin Chingin, Huanwen Chen, et al. (+11)
203 [GO] 2021―Mar―09 Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19 Monika Maria Biernat, Anna Kolasińska, Jacek Kwiatkowski, Donata Urbaniak-Kujda, Paweł Biernat, Justyna Janocha-Litwin, et al. (+6)
204 [GO] 2021―Mar―09 Experimental Inoculation of Young Calves with SARS-CoV-2 Shollie Falkenberg, Alexandra Buckley, Melissa Laverack, Mathias Martins, Mitchell V. Palmer, Kelly Lager, Diego G. Diel
205 [GO] 2021―Mar―09 Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications Jasdeep Singh, Jasmine Samal, Vipul Kumar, Jyoti Sharma, Usha Agrawal, Nasreen Z. Ehtesham, et al. (+4)
206 [GO] 2021―Mar―08 The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2 Javed Akhter, Grégory Quéromès, Krishna Pillai, Vahan Kepenekian, Samina Badar, Ahmed H. Mekkawy, et al. (+3)
207 [GO] 2021―Mar―05 Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19 Fares Qeadan, Benjamin Tingey, Lily Y. Gu, Ashley Hafen Packard, Esther Erdei, Ali I. Saeed
208 [GO] 2021―Mar―05 Pharmacogenetics Approach for the Improvement of COVID-19 Treatment Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
209 [GO] 2021―Mar―05 Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection Federico Gobbi, Dora Buonfrate, Lucia Moro, Paola Rodari, Chiara Piubelli, Sara Caldrer, et al. (+3)
210 [GO] 2021―Mar―05 Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective Colin D. Funk, Craig Laferrière, Ali Ardakani
211 [GO] 2021―Mar―05 Antiviral Activity of the PropylamylatinTM Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions Ashley N. Brown, Gary Strobel, Kaley C. Hanrahan, Joe Sears
212 [GO] 2021―Mar―05 Evaluation of a Lyophilized CRISPR-Cas12 Assay for a Sensitive, Specific, and Rapid Detection of SARS-CoV-2 Lucía Ana Curti, Ivana Primost, Sofia Valla, Daiana Ibañez Alegre, Cecilia Olguin Perglione, Guillermo Daniel Repizo, et al. (+9)
213 [GO] 2021―Mar―05 SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Desirée Bartolini, et al. (+6)
214 [GO] 2021―Mar―04 mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection Sumit Mukherjee, Bodhisattwa Banerjee, David Karasik, Milana Frenkel-Morgenstern
215 [GO] 2021―Mar―02 The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense Cem Azgari, Zeynep Kilinc, Berk Turhan, Defne Circi, Ogun Adebali
216 [GO] 2021―Mar―01 TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein Mai Kishimoto, Kentaro Uemura, Takao Sanaki, Akihiko Sato, William W. Hall, Hiroaki Kariwa, et al. (+3)
217 [GO] 2021―Mar―01 SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, Tomasz Lipniacki
218 [GO] 2021―Feb―28 In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic Rafael B. Rosa, Willyenne M. Dantas, Jessica C. F. do Nascimento, Murilo V. da Silva, Ronaldo N. de Oliveira, Lindomar J. Pena
219 [GO] 2021―Feb―28 Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review Apparao Peddapalli, Manish Gehani, Arunasree M. Kalle, Siva R. Peddapalli, Angela E. Peter andShashwat Sharad
220 [GO] 2021―Feb―26 In Silico, In Vitro and In Cellulo Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion Delphine Lapaillerie, Cathy Charlier, Henrique S. Fernandes, Sergio F. Sousa, Paul Lesbats, Pierre Weigel, et al. (+3)
221 [GO] 2021―Feb―24 Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan Hidenori Matsunaga, Akiko Makino, Yasuhiro Kato, Teruaki Murakami, Yuta Yamaguchi, Atsushi Kumanogoh, et al. (+4)
222 [GO] 2021―Feb―24 Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro Sébastien Pasquereau, Zeina Nehme, Sandy Haidar Haidar Ahmad, Fadoua Daouad, Jeanne Van Assche Clémentine Wallet, Christian Schwartz, et al. (+3)
223 [GO] 2021―Feb―24 Erasing the Invisible Line to Empower the Pandemic Response Nicola Decaro, Alessio Lorusso, Ilaria Capua
224 [GO] 2021―Feb―23 On the Prevalence and Potential Functionality of an Intrinsic Disorder in the MERS-CoV Proteome Manal A. Alshehri, Manee M. Manee, Fahad H. Alqahtani, Badr M. Al-Shomrani, Vladimir N. Uversky
225 [GO] 2021―Feb―23 Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1 Gloria Pérez-Rubio, Marco Antonio Ponce-Gallegos, Bruno André Domínguez-Mazzocco, Jaime Ponce-Gallegos, Román Alejandro García-Ramírez, Ramcés Falfán-Valencia
226 [GO] 2021―Feb―22 Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2 Ling Jin, Wendy Black, Teresa Sawyer
227 [GO] 2021―Feb―22 Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea Seongman Bae, Byeongzu Ghang, Ye-Jee Kim, Joon Seo Lim, Sung-Cheol Yun, Yong-Gil Kim, et al. (+2)
228 [GO] 2021―Feb―19 Viral Vectors for COVID-19 Vaccine Development Kenneth Lundstrom
229 [GO] 2021―Feb―18 Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections Ben M. Flude, Giulio Nannetti, Paige Mitchell, Nina Compton, Chloe Richards, Meike Heurich, et al. (+3)
230 [GO] 2021―Feb―16 Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19 Eli Mansour, Andre C. Palma, Raisa G. Ulaf, Luciana C. Ribeiro, Ana Flavia Bernardes, Thyago A. Nunes, et al. (+14)
231 [GO] 2021―Feb―16 Honeysuckle Aqueous Extracts Induced let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2 Ying-Ray Lee, Chia-Ming Chang, Yuan-Chieh Yeh, Chi-Ying F. Huang, Feng-Mao Lin, Juan-Ting Huang, et al. (+3)
232 [GO] 2021―Feb―16 Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches Shiv Bharadwaj, Sherif Aly El-Kafraway, Thamir A. Alandijany, Leena Hussein Bajrai, Altaf Ahmad Shah, Amit Dubey, et al. (+6)
233 [GO] 2021―Feb―15 Relationships between Viral Load and the Clinical Course of COVID-19 Hiroyuki Tsukagoshi, Daisuke Shinoda, Mariko Saito, Kaori Okayama, Mitsuru Sada, Hirokazu Kimura, Nobuhiro Saruki
234 [GO] 2021―Feb―14 Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture Allison Bakovic, Kenneth Risner, Nishank Bhalla, Farhang Alem, Theresa L. Chang, Warren K. Weston, et al. (+2)
235 [GO] 2021―Feb―12 Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults Hulda R. Jonsdottir, Michel Bielecki, Denise Siegrist, Thomas W. Buehrer, Roland Züst, Jeremy W. Deuel
236 [GO] 2021―Feb―12 Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients Mattia Trunfio, Francesco Venuti, Francesca Alladio, Bianca Maria Longo, Elisa Burdino, Francesco Cerutti, et al. (+6)
237 [GO] 2021―Feb―12 Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, et al. (+5)
238 [GO] 2021―Feb―05 SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays Gregory J. Walker, Zin Naing, Alberto Ospina Stella, Malinna Yeang, Joanna Caguicla, Vidiya Ramachandran, et al. (+12)
239 [GO] 2021―Feb―05 Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
240 [GO] 2021―Feb―04 Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients Sebastian Deschler, Juliane Kager, Johanna Erber, Lisa Fricke, Plamena Koyumdzhieva, Alexandra Georgieva, et al. (+16)
241 [GO] 2021―Feb―04 Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus Sarah Al-Beltagi, Cristian Alexandru Preda, Leah V. Goulding, Joe James, Juan Pu, Paul Skinner, et al. (+11)
242 [GO] 2021―Feb―02 Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality Eric Dumonteil, Dahlene Fusco, Arnaud Drouin, Claudia Herrera
243 [GO] 2021―Feb―02 The SARS-CoV-2-Inactivating Activity of Hydroxytyrosol-Rich Aqueous Olive Pulp Extract (HIDROX®) and Its Use as a Virucidal Cream for Topical Application Yohei Takeda, Dulamjav Jamsransuren, Sachiko Matsuda, Roberto Crea, Haruko Ogawa
244 [GO] 2021―Jan―29 COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention Anshika Sharma, Isra Ahmad Farouk, Sunil Kumar Lal
245 [GO] 2021―Jan―27 Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic Margaret J. Hosie, Regina Hofmann-Lehmann, Katrin Hartmann, Herman Egberink, Uwe Truyen, Diane D. Addie, et al. (+10)
246 [GO] 2021―Jan―27 Diagnostic Value of Detecting Feline Coronavirus RNA and Spike Gene Mutations in Cerebrospinal Fluid to Confirm Feline Infectious Peritonitis Sandra Felten, Kaspar Matiasek, Christian M. Leutenegger, Laura Sangl, Stephanie Herre, Stefanie Dörfelt, et al. (+2)
247 [GO] 2021―Jan―25 ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data Jacques Le Pendu, Adrien Breiman, Jézabel Rocher, Michel Dion, Nathalie Ruvoën-Clouet
248 [GO] 2021―Jan―25 Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors Jonathan M. O. Rawson, Alice Duchon, Olga A. Nikolaitchik, Vinay K. Pathak, Wei-Shau Hu
249 [GO] 2021―Jan―25 Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 Gordon J. Lockbaum, Archie C. Reyes, Jeong Min Lee, Ronak Tilvawala, Ellen A. Nalivaika, Akbar Ali, et al. (+3)
250 [GO] 2021―Jan―25 Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy Elyse Latreille, Warren L. Lee
251 [GO] 2021―Jan―21 Chimeric Porcine Deltacoronaviruses with Sparrow Coronavirus Spike Protein or the Receptor-Binding Domain Infect Pigs but Lose Virulence and Intestinal Tropism Xiaoyu Niu, Yixuan J. Hou, Kwonil Jung, Fanzhi Kong, Linda J. Saif, Qiuhong Wang
252 [GO] 2021―Jan―21 A 10-Minute “Mix and Read” Antibody Assay for SARS-CoV-2 Juuso Rusanen, Lauri Kareinen, Lev Levanov, Sointu Mero, Sari H. Pakkanen, Anu Kantele, et al. (+5)
253 [GO] 2021―Jan―21 Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection Helen E. Everett, Fabian Z. X. Lean, Alexander M. P. Byrne, Pauline M. van Diemen, Shelley Rhodes, Joe James, et al. (+14)
254 [GO] 2021―Jan―21 MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species Sigrun Lange, Elif Damla Arisan, Guy H. Grant, Pinar Uysal-Onganer
255 [GO] 2021―Jan―21 Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients Bandar Alosaimi, Asif Naeem, Majed F. Alghoribi, Lilian Okdah, Maaweya E. Hamed, Ahmad S. AlYami, et al. (+2)
256 [GO] 2021―Jan―21 Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice Pratima Kumari, Hussin A. Rothan, Janhavi P. Natekar, Shannon Stone, Heather Pathak, Philip G. Strate, et al. (+3)
257 [GO] 2021―Jan―21 Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada Adriana Peci, Vanessa Tran, Jennifer L. Guthrie, Ye Li, Paul Nelson, Kevin L. Schwartz, et al. (+3)
258 [GO] 2021―Jan―21 Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women Monica Cruz-Lemini, Elena Ferriols Perez, Maria de la Cruz Conty, Africa Caño Aguilar, Maria Encinas Pardilla, Pilar Prats Rodríguez, et al. (+47)
259 [GO] 2021―Jan―21 Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia Alix Armero, Nicolas Berthet, Jean-Christophe Avarre
260 [GO] 2021―Jan―21 Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies Maxwell T. Finkelstein, Adam G. Mermelstein, Emma Parker Miller, Paul C. Seth, Erik-Stephane D. Stancofski, Daniela Fera
261 [GO] 2021―Jan―21 Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro Mónica Salas Rojas, Raúl Silva Garcia, Estela Bini, Verónica Pérez de la Cruz, Juan Carlos León Contreras, Rogelio Hernández Pando, et al. (+6)
262 [GO] 2021―Jan―15 Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design Xuhua Xia
263 [GO] 2021―Jan―14 Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug Camilla Isgrò, Anna Maria Sardanelli, Luigi Leonardo Palese
264 [GO] 2021―Jan―12 The Fatty Acid Lipid Metabolism Nexus in COVID-19 Jerome E. Tanner, Caroline Alfieri
265 [GO] 2021―Jan―11 Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection Anup Oommen, Stephen Cunningham, Lokesh Joshi
266 [GO] 2021―Jan―07 Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro Mei Hashizume, Gabriel Gonzalez, Chikako Ono, Ayako Takashima, Masaharu Iwasaki
267 [GO] 2020―Dec―31 Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities Qiong Zhou, Michael R. MacArthur, Xinliang He, Xiaoshan Wei, Payam Zarin, Bola S. Hanna, et al. (+3)
268 [GO] 2020―Dec―31 Markers Associated with COVID-19 Susceptibility, Resistance, and Severity Aisha D. Fakhroo, Asmaa A. Al Thani, Hadi M. Yassine
269 [GO] 2020―Dec―31 Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations Nicholas J. Dimonaco, Mazdak Salavati, Barbara B. Shih
270 [GO] 2020―Dec―31 PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity Sijia He, Abdul A. Waheed, Brian Hetrick, Deemah Dabbagh, Ivan V. Akhrymuk, Kylene Kehn-Hall, et al. (+2)
271 [GO] 2020―Dec―31 Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval Ebenezer Tumban
272 [GO] 2020―Dec―31 SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production Keli Chen, Feng Xiao, Dingwen Hu, Weiwei Ge, Mingfu Tian, Wenbiao Wang, et al. (+3)
273 [GO] 2020―Dec―30 The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Valdir Gomes Barbosa-Júnior, Milena Botelho Pereira Soares, Roberto Badaró
274 [GO] 2020―Dec―28 Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman
275 [GO] 2020―Dec―25 Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2 Svetlana Khaiboullina, Timsy Uppal, Nikhil Dhabarde, Vaidyanathan Ravi Subramanian, Subhash C. Verma
276 [GO] 2020―Dec―25 Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection Nikolaos Orologas-Stavrou, Marianna Politou, Pantelis Rousakis, Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Edison Jahaj, et al. (+7)
277 [GO] 2020―Dec―23 Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV Stacey L. P. Scroggs, Danielle K. Offerdahl, Dylan P. Flather, Ciera N. Morris, Benjamin L. Kendall, Rebecca M. Broeckel, et al. (+2)
278 [GO] 2020―Dec―23 Structure and Hierarchy of SARS-CoV-2 Infection Dynamics Models Revealed by Reaction Network Analysis Stephan Peter, Peter Dittrich, Bashar Ibrahim
279 [GO] 2020―Dec―21 Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization? Luca De Sabato, Ilaria Di Bartolo, Maria Alessandra De Marco, Ana Moreno, Davide Lelli, Claudia Cotti, et al. (+2)
280 [GO] 2020―Dec―21 The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region Junxing Zhao, Jianming Qiu, Sadikshya Aryal, Jennifer L. Hackett, Jingxin Wang
281 [GO] 2020―Dec―18 SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus Katherine Elizabeth Havranek, Ariana R. Jimenez, Marissa Danielle Acciani, Maria Fernanda Lay Mendoza, Judith Mary Reyes Ballista, Darren Austin Diaz, Melinda Ann Brindley
282 [GO] 2020―Dec―17 Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins Maria Fernanda Lay Mendoza, Marissa Danielle Acciani, Courtney Nina Levit, Christopher Santa Maria, Melinda Ann Brindley
283 [GO] 2020―Dec―15 Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy Francesca Di Giallonardo, Sebastian Duchene, Ilaria Puglia, Valentina Curini, Francesca Profeta, Cesare Cammà, et al. (+4)
284 [GO] 2020―Dec―14 Dysregulated Interferon Response Underlying Severe COVID-19 LeAnn Lopez, Peter C. Sang, Yun Tian, Yongming Sang
285 [GO] 2020―Dec―11 Comparison of Rapid Antigen Tests for COVID-19 Seiya Yamayoshi, Yuko Sakai-Tagawa, Michiko Koga, Osamu Akasaka, Ichiro Nakachi, Hidefumi Koh, et al. (+24)
286 [GO] 2020―Dec―10 Changes in Mass Treatment of the Canine Parvovirus ICU Population in Relation to Public Policy Changes during the COVID-19 Pandemic Kevin Horecka, Nipuni Ratnayaka, Elizabeth A. Davis
287 [GO] 2020―Dec―09 Bat-Borne Coronaviruses in Jordan and Saudi Arabia: A Threat to Public Health? Laith N. AL-Eitan, Amneh H. Tarkhan, Mansour A. Alghamdi, Denise A. Marston, Guanghui Wu, Lorraine M. McElhinney, et al. (+2)
288 [GO] 2020―Dec―09 Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil Marcelo Henrique Santos Paiva, Duschinka Ribeiro Duarte Guedes, Cássia Docena, Matheus Filgueira Bezerra, Filipe Zimmer Dezordi, Laís Ceschini Machado, et al. (+24)
289 [GO] 2020―Dec―07 Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix Gábor Kemenesi, Safia Zeghbib, Balázs A Somogyi, Gábor Endre Tóth, Krisztián Bányai, Norbert Solymosi, et al. (+16)
290 [GO] 2020―Dec―04 Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients Anwar M. Hashem, Abdullah Algaissi, Sarah A. Almahboub, Mohamed A. Alfaleh, Turki S. Abujamel, Sawsan S. Alamri, et al. (+19)
291 [GO] 2020―Dec―04 Disease Pandemics and Major Epidemics Arising from New Encounters between Indigenous Viruses and Introduced Crops Roger A. C. Jones
292 [GO] 2020―Dec―03 Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients Michael Zapor
293 [GO] 2020―Dec―01 Non-Coding RNAs and SARS-Related Coronaviruses Hanna Henzinger, Dominik A. Barth, Christiane Klec, Martin Pichler
294 [GO] 2020―Nov―30 Application of a Photocatalyst as an Inactivator of Bovine Coronavirus Nobuki Yoshizawa, Ryoko Ishihara, Daisuke Omiya, Midori Ishitsuka, Shouichirou Hirano, Tohru Suzuki
295 [GO] 2020―Nov―30 Camelid Inoculation With Middle East Respiratory Syndrome Coronavirus: Experimental Models of Reservoir Host Infection Danielle R. Adney, Chad S. Clancy, Richard A. Bowen, Vincent J. Munster
296 [GO] 2020―Nov―30 Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System Fabrizio Pucci, Philippe Bogaerts, Marianne Rooman
297 [GO] 2020―Nov―27 Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients Bertram Flehmig, Michael Schindler, Natalia Ruetalo, Ramona Businger, Manfred Bayer, Angelika Haage, et al. (+6)
298 [GO] 2020―Nov―23 COVID-19 and School Activities in Italy Giovanni Sebastiani, Giorgio Palé
299 [GO] 2020―Nov―20 Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality Atsushi Sakuraba, Haider Haider, Toshiro Sato
300 [GO] 2020―Nov―19 Fatal Interstitial Pneumonia Associated with Bovine Coronavirus in Cows from Southern Italy Maria Grazia Amoroso, Giuseppe Lucifora, Barbara Degli Uberti, Francesco Serra, Giovanna De Luca, Giorgia Borriello, et al. (+7)
301 [GO] 2020―Nov―18 Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19 Kenneth Lundstrom
302 [GO] 2020―Nov―18 Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model Yoonjung Choi, Bonggun Shin, Keunsoo Kang, Sungsoo Park, Bo Ram Beck
303 [GO] 2020―Nov―17 Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients Christopher Kandel, Jennifer Zheng, Janine McCready, Mihaela Anca Serbanescu, Hilary Racher, Melissa Desaulnier, et al. (+9)
304 [GO] 2020―Nov―16 Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2 David A. Schwartz, Denise Morotti
305 [GO] 2020―Nov―12 Spike Glycoprotein-Mediated Entry of SARS Coronaviruses Lin Wang, Ye Xiang
306 [GO] 2020―Nov―12 Transcriptional Immune Signatures of Alveolar Macrophages and the Impact of the NLRP3 Inflammasome on Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Replication Julie A. Hicks, Dongwan Yoo, Hsiao-Ching Liu
307 [GO] 2020―Nov―10 Bovine Coronavirus: Variability, Evolution, and Dispersal Patterns of a No Longer Neglected Betacoronavirus Giovanni Franzo, Michele Drigo, Matteo Legnardi, Laura Grassi, Daniela Pasotto, Maria Luisa Menandro, et al. (+2)
308 [GO] 2020―Nov―10 CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study Joan Calvet, Jordi Gratacós, María José Amengual, Maria Llop, Marta Navarro, Amàlia Moreno, et al. (+4)
309 [GO] 2020―Nov―03 First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region Bourema Kouriba, Angela Dürr, Alexandra Rehn, Abdoul Karim Sangaré, Brehima Y. Traoré, Malena S. Bestehorn-Willmann, et al. (+8)
310 [GO] 2020―Nov―01 Porcine Reproductive and Respiratory Syndrome Virus Reverse Genetics and the Major Applications Jayeshbhai Chaudhari, Hiep L. X. Vu
311 [GO] 2020―Oct―30 COVID-19: Look to the Future, Learn from the Past Zhangkai J. Cheng, Hui-Qi Qu, Lifeng Tian, Zhifeng Duan, Hakon Hakonarson
312 [GO] 2020―Oct―29 Polymorphisms in Processing and Antigen Presentation-Related Genes and Their Association with Host Susceptibility to Influenza A/H1N1 2009 Pandemic in a Mexican Mestizo Population Marco Antonio Ponce-Gallegos, Aseneth Ruiz-Celis, Enrique Ambrocio-Ortiz, Gloria Pérez-Rubio, Alejandra Ramírez-Venegas, Nora E. Bautista-Félix, Ramcés Falfán-Valencia
313 [GO] 2020―Oct―27 Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization Shilei Ding, Annemarie Laumaea, Mehdi Benlarbi, Guillaume Beaudoin-Bussières, Romain Gasser, Halima Medjahed, et al. (+5)
314 [GO] 2020―Oct―27 High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019 Taibah A. Aljasim, Abdulrahman Almasoud, Haya A. Aljami, Mohamed W. Alenazi, Suliman A. Alsagaby, Asma N. Alsaleh, Naif Khalaf Alharbi
315 [GO] 2020―Oct―26 The Cell Tropism of Porcine Respiratory Coronavirus for Airway Epithelial Cells Is Determined by the Expression of Porcine Aminopeptidase N Ju-Yi Peng, Darsaniya Punyadarsaniya, Dai-Lun Shin, Suvarin Pavasutthipaisit, Andreas Beineke, Guangxing Li, et al. (+2)
316 [GO] 2020―Oct―26 Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing David van Bockel, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory Walker, Alberto Ospina Stella, et al. (+11)
317 [GO] 2020―Oct―22 Viewpoint: Origin of SARS-CoV-2 Kenneth Lundstrom, Murat Seyran, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Sk. Sarif Hassan, et al. (+11)
318 [GO] 2020―Oct―20 Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Pierluca Piselli, Francesca Colavita, Emanuele Nicastri, et al. (+11)
319 [GO] 2020―Oct―17 Viral Related Tools against SARS-CoV-2 Laura Fernandez-Garcia, Olga Pacios, Mónica González-Bardanca, Lucia Blasco, Inés Bleriot, Antón Ambroa, et al. (+3)
320 [GO] 2020―Oct―17 Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract Yichuan Liu, Hui-Qi Qu, Jingchun Qu, Lifeng Tian, Hakon Hakonarson
321 [GO] 2020―Oct―15 Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism Shona C. Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, Nadine Randle, Stuart Armstrong, Catherine Hartley, et al. (+40)
322 [GO] 2020―Oct―09 Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic Javier Martin, Dimitra Klapsa, Thomas Wilton, Maria Zambon, Emma Bentley, Erika Bujaki, et al. (+3)
323 [GO] 2020―Sep―30 Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins Sai Priya Anand, Yaozong Chen, Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, Cameron F. Abrams, et al. (+2)
324 [GO] 2020―Sep―29 Treatment with Exogenous Trypsin Expands In Vitro Cellular Tropism of the Avian Coronavirus Infectious Bronchitis Virus Phoebe Stevenson-Leggett, Sarah Keep, Erica Bickerton
325 [GO] 2020―Sep―28 Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning Emily E. Ackerman, Jason E. Shoemaker
326 [GO] 2020―Sep―28 Host Immune Response Driving SARS-CoV-2 Evolution Rui Wang, Yuta Hozumi, Yong-Hui Zheng, Changchuan Yin, Guo-Wei Wei
327 [GO] 2020―Sep―25 Meta-Transcriptomic Discovery of a Divergent Circovirus and a Chaphamaparvovirus in Captive Reptiles with Proliferative Respiratory Syndrome Wei-Shan Chang, Ci-Xiu Li, Jane Hall, John-Sebastian Eden, Timothy H. Hyndman, Edward C. Holmes, Karrie Rose
328 [GO] 2020―Sep―23 Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak Zheng Yao Low, Isra Ahmad Farouk, Sunil Kumar Lal
329 [GO] 2020―Sep―22 Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus Entedar A. J. Alsaadi, Benjamin W. Neuman, Ian M. Jones
330 [GO] 2020―Sep―18 RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients Kirsten Alexandra Eberhardt, Charlotte Meyer-Schwickerath, Eva Heger, Elena Knops, Clara Lehmann, Jan Rybniker, et al. (+9)
331 [GO] 2020―Sep―18 Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses Ping Liu, Yan Hong, Bincai Yang, Prasha Shrestha, Nelam Sajjad, Ji-Long Chen
332 [GO] 2020―Sep―14 Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features Christine Haake, Sarah Cook, Nicola Pusterla, Brian Murphy
333 [GO] 2020―Sep―14 Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic Jiaxin Ling, Rachel A. Hickman, Jinlin Li, Xi Lu, Johanna F. Lindahl, Åke Lundkvist, Josef D. Järhult
334 [GO] 2020―Sep―10 Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays Inesa Hyseni, Eleonora Molesti, Linda Benincasa, Pietro Piu, Elisa Casa, Nigel J Temperton, et al. (+2)
335 [GO] 2020―Sep―09 Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds Philip L. Tzou, Kaiming Tao, Janin Nouhin, Soo-Yon Rhee, Benjamin D. Hu, Shruti Pai, et al. (+2)
336 [GO] 2020―Sep―09 Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus Sang Ah Yi, Ki Hong Nam, Jihye Yun, Dongmin Gim, Daeho Joe, Yong Ho Kim, et al. (+3)
337 [GO] 2020―Sep―08 Prevalence of Feline Coronavirus Shedding in German Catteries and Associated Risk Factors Ute Klein-Richers, Katrin Hartmann, Regina Hofmann-Lehmann, Stefan Unterer, Michèle Bergmann, Anna Rieger, et al. (+4)
338 [GO] 2020―Sep―07 Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice Andrea N. Loes, Lauren E. Gentles, Allison J. Greaney, Katharine H. D. Crawford, Jesse D. Bloom
339 [GO] 2020―Sep―02 Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2 Mohammed A. Rohaim, Emily Clayton, Irem Sahin, Julianne Vilela, Manar E. Khalifa, Mohammad Q. Al-Natour, et al. (+22)
340 [GO] 2020―Aug―27 Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger Jean-Paul Pirnay, Philippe Selhorst, Christel Cochez, Mauro Petrillo, Vincent Claes, Yolien Van der Beken, et al. (+11)
341 [GO] 2020―Aug―26 HIV and Human Coronavirus Coinfections: A Historical Perspective Palesa Makoti, Burtram C. Fielding
342 [GO] 2020―Aug―26 Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site Shana V. Stoddard, Serena D. Stoddard, Benjamin K. Oelkers, Kennedi Fitts, Kellen Whalum, Kaylah Whalum, et al. (+11)
343 [GO] 2020―Aug―19 The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV Mayanka Awasthi, Sahil Gulati, Debi P. Sarkar, Swasti Tiwari, Suneel Kateriya, Peeyush Ranjan, Santosh Kumar Verma
344 [GO] 2020―Aug―17 A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture Jalees A. Nasir, Robert A. Kozak, Patryk Aftanas, Amogelang R. Raphenya, Kendrick M. Smith, Finlay Maguire, et al. (+11)
345 [GO] 2020―Aug―12 Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2 Robert W. Körner, Mohamed Majjouti, Miguel A. Alejandre Alcazar, Esther Mahabir
346 [GO] 2020―Aug―07 Vaccine Candidates Against Coronavirus Infections. Where Does COVID-19 Stand? Jawad Al-Kassmy, Jannie Pedersen, Gary Kobinger
347 [GO] 2020―Aug―07 SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP Steffen Klein, Thorsten G. Müller, Dina Khalid, Vera Sonntag-Buck, Anke-Mareil Heuser, Bärbel Glass, et al. (+20)
348 [GO] 2020―Aug―05 Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa Audrey Lacroix, Nicole Vidal, Alpha K. Keita, Guillaume Thaurignac, Amandine Esteban, Hélène De Nys, et al. (+13)
349 [GO] 2020―Aug―05 Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory Neta S. Zuckerman, Rakefet Pando, Efrat Bucris, Yaron Drori, Yaniv Lustig, Oran Erster, et al. (+3)
350 [GO] 2020―Aug―04 Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry Petra Wandernoth, Katharina Kriegsmann, Cristina Groh-Mohanu, Martin Daeumer, Peter Gohl, Oliver Harzer, et al. (+2)
351 [GO] 2020―Jul―29 Host Transcriptional Response to Persistent Infection with a Live-Attenuated Porcine Reproductive and Respiratory Syndrome Virus Strain Jayeshbhai Chaudhari, Chia-Sin Liew, Aspen M. Workman, Jean-Jack M. Riethoven, David Steffen, Sarah Sillman, Hiep L. X. Vu
352 [GO] 2020―Jul―27 In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection Annamaria Martorana, Carla Gentile, Antonino Lauria
353 [GO] 2020―Jul―27 Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic Alessia Lai, Annalisa Bergna, Sara Caucci, Nicola Clementi, Ilaria Vicenti, Filippo Dragoni, et al. (+14)
354 [GO] 2020―Jul―20 Tiotropium Is Predicted to Be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis Keunsoo Kang, Hoo Hyun Kim, Yoonjung Choi
355 [GO] 2020―Jul―20 Covid-19 Transmission Trajectories-Monitoring the Pandemic in the Worldwide Context Henry Loeffler-Wirth, Maria Schmidt, Hans Binder
356 [GO] 2020―Jul―20 Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters Nikolaus Osterrieder, Luca D. Bertzbach, Kristina Dietert, Azza Abdelgawad, Daria Vladimirova, Dusan Kunec, et al. (+4)
357 [GO] 2020―Jul―17 Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections Ahmed Sedik, Abdullah M Iliyasu, Basma Abd El-Rahiem, Mohammed E. Abdel Samea, Asmaa Abdel-Raheem, Mohamed Hammad, et al. (+3)
358 [GO] 2020―Jul―14 Temperature Sensitivity: A Potential Method for the Generation of Vaccines against the Avian Coronavirus Infectious Bronchitis Virus Sarah Keep, Phoebe Stevenson-Leggett, Angela Steyn, Michael S. Oade, Isobel Webb, Jamie Stuart, et al. (+4)
359 [GO] 2020―Jul―07 Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? Boris Pastorino, Franck Touret, Magali Gilles, Xavier de Lamballerie, Remi N. Charrel
360 [GO] 2020―Jun―30 Early Phase of the COVID-19 Outbreak in Hungary and Post-Lockdown Scenarios Gergely Röst, Ferenc A. Bartha, Norbert Bogya, Péter Boldog, Attila Dénes, Tamás Ferenci, et al. (+6)
361 [GO] 2020―Jun―30 Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review Jennifer Santos, Stephanie Brierley, Mohit J. Gandhi, Michael A. Cohen, Phillip C. Moschella, Arwen B. L. Declan
362 [GO] 2020―Jun―29 Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2 Yohei Takeda, Toshihiro Murata, Dulamjav Jamsransuren, Keisuke Suganuma, Yuta Kazami, Javzan Batkhuu, et al. (+2)
363 [GO] 2020―Jun―26 Development and Evaluation of a duo SARS-CoV-2 RT-qPCR Assay Combining Two Assays Approved by the World Health Organization Targeting the Envelope and the RNA-Dependant RNA Polymerase (RdRp) Coding Regions Laura Pezzi, Remi N. Charrel, Laetitia Ninove, Antoine Nougairede, Gregory Molle, Bruno Coutard, et al. (+4)
364 [GO] 2020―Jun―24 Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model Elizabeth A. Pharo, Sinéad M. Williams, Victoria Boyd, Vinod Sundaramoorthy, Peter A. Durr, Michelle L. Baker
365 [GO] 2020―Jun―17 Porcine Reproductive and Respiratory Syndrome Virus Antagonizes PCSK9’s Antiviral Effect via Nsp11 Endoribonuclease Activity Yujiao Zhang, Fei Gao, Liwei Li, Kuan Zhao, Shan Jiang, Yifeng Jiang, et al. (+4)
366 [GO] 2020―Jun―15 A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19 Jean-Michel Claverie
367 [GO] 2020―Jun―15 Potential Antiviral Options against SARS-CoV-2 Infection Aleksandr Ianevski, Rouan Yao, Mona Høysæter Fenstad, Svetlana Biza, Eva Zusinaite, Tuuli Reisberg, et al. (+14)
368 [GO] 2020―Jun―12 Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19) Shuofeng Yuan, Chris Chun-Yiu Chan, Kenn Ka-Heng Chik, Jessica Oi-Ling Tsang, Ronghui Liang, Jianli Cao, et al. (+10)
369 [GO] 2020―Jun―12 Epidemiology and Clinical Symptoms Related to Seasonal Coronavirus Identified in Patients with Acute Respiratory Infections Consulting in Primary Care over Six Influenza Seasons (2014-2020) in France Shirley Masse, Lisandru Capai, Natacha Villechenaud, Thierry Blanchon, Rémi Charrel, Alessandra Falchi
370 [GO] 2020―Jun―12 The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner Mizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa, Kiyoko Iwatsuki-Horimoto, Masaki Imai, Makoto Takeda, et al. (+8)
371 [GO] 2020―Jun―09 Propagation, Inactivation, and Safety Testing of SARS-CoV-2 Alexander S. Jureka, Jesus A. Silvas, Christopher F. Basler
372 [GO] 2020―Jun―09 Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples Boris Pastorino, Franck Touret, Magali Gilles, Lea Luciani, Xavier de de Lamballerie, Remi N. Charrel
373 [GO] 2020―Jun―05 The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities Elif Damla Arisan, Alwyn Dart, Guy H. Grant, Serdar Arisan, Songul Cuhadaroglu, Sigrun Lange, Pinar Uysal-Onganer
374 [GO] 2020―Jun―04 Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia Badr M. Al-Shomrani, Manee M. Manee, Sultan N. Alharbi, Mussad A. Altammami, Manal A. Alshehri, Majed S. Nassar, et al. (+2)
375 [GO] 2020―May―28 Spatial-Temporal Variations in Atmospheric Factors Contribute to SARS-CoV-2 Outbreak Raffaele Fronza, Marina Lusic, Manfred Schmidt, Bojana Lucic
376 [GO] 2020―May―27 Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 Nadin Younes, Duaa W. Al-Sadeq, Hadeel AL-Jighefee, Salma Younes, Ola Al-Jamal, Hanin I. Daas, et al. (+2)
377 [GO] 2020―May―25 Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection Tomomi Takano, Kumi Satoh, Tomoyoshi Doki, Taishi Tanabe, Tsutomu Hohdatsu
378 [GO] 2020―May―14 Detection of Recombinant Rousettus Bat Coronavirus GCCDC1 in Lesser Dawn Bats (Eonycteris spelaea) in Singapore Adrian C. Paskey, Justin H. J. Ng, Gregory K. Rice, Wan Ni Chia, Casandra W. Philipson, Randy J. H. Foo, et al. (+12)
379 [GO] 2020―May―14 Global Transmission, Spatial Segregation, and Recombination Determine the Long-Term Evolution and Epidemiology of Bovine Coronaviruses Elias Salem, Vijaykrishna Dhanasekaran, Herve Cassard, Ben Hause, Sarah Maman, Gilles Meyer, Mariette F. Ducatez
380 [GO] 2020―May―14 The Phylogeography of MERS-CoV in Hospital Outbreak-Associated Cases Compared to Sporadic Cases in Saudi Arabia Xin Chen, Dillon Charles Adam, Abrar Ahmad Chughtai, Sacha Stelzer-Braid, Matthew Scotch, Chandini Raina MacIntyre
381 [GO] 2020―May―11 Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review Maryam Aboughdir, Thomas Kirwin, Ashiq Abdul Khader, Brian Wang
382 [GO] 2020―May―11 SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, Tom Loney, Hanan Al Suwaidi, Ahmed H. Hassan Al-Marzouqi, et al. (+7)
383 [GO] 2020―May―07 Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays Katharine H. D. Crawford, Rachel Eguia, Adam S. Dingens, Andrea N. Loes, Keara D. Malone, Caitlin R. Wolf, et al. (+8)
384 [GO] 2020―May―04 Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Asif Naeem, Maaweya E. Hamed, Majed F. Alghoribi, Waleed Aljabr, Hadel Alsaran, Mushira A. Enani, Bandar Alosaimi
385 [GO] 2020―May―04 Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes Maddalena Dilucca, Sergio Forcelloni, Alexandros G. Georgakilas, Andrea Giansanti, Athanasia Pavlopoulou
386 [GO] 2020―Apr―30 The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor Esther S. Brielle, Dina Schneidman-Duhovny, Michal Linial
387 [GO] 2020―Apr―28 Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19 Santosh Kumar, Kaining Zhi, Ahona Mukherji, Kelli Gerth
388 [GO] 2020―Apr―28 ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa
389 [GO] 2020―Apr―23 Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19 Sherif T. S. Hassan
390 [GO] 2020―Apr―15 Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs Paolo Calligari, Sara Bobone, Giorgio Ricci, Alessio Bocedi
391 [GO] 2020―Apr―13 Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 Jiahua He, Huanyu Tao, Yumeng Yan, Sheng-You Huang, Yi Xiao
392 [GO] 2020―Apr―07 In Silico Discovery of Candidate Drugs against Covid-19 Claudia Cava, Gloria Bertoli, Isabella Castiglioni
393 [GO] 2020―Apr―06 Role of Porcine Aminopeptidase N and Sialic Acids in Porcine Coronavirus Infections in Primary Porcine Enterocytes Tingting Cui, Sebastiaan Theuns, Jiexiong Xie, Wim Van den Broeck, Hans J. Nauwynck
394 [GO] 2020―Apr―06 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Seropositive Camel Handlers in Kenya Alice N. Kiyong’a, Elizabeth A. J. Cook, Nisreen M. A. Okba, Velma Kivali, Chantal Reusken, Bart L. Haagmans, Eric M. Fèvre
395 [GO] 2020―Mar―31 Virology, Epidemiology, Pathogenesis, and Control of COVID-19 Yuefei Jin, Haiyan Yang, Wangquan Ji, Weidong Wu, Shuaiyin Chen, Weiguo Zhang, Guangcai Duan
396 [GO] 2020―Mar―31 Key Role of the Influenza A Virus PA Gene Segment in the Emergence of Pandemic Viruses Michael M. Lutz, Megan M. Dunagan, Yuki Kurebayashi, Toru Takimoto
397 [GO] 2020―Mar―25 Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins Suhas Srinivasan, Hongzhu Cui, Ziyang Gao, Ming Liu, Senbao Lu, Winnie Mkandawire, et al. (+3)
398 [GO] 2020―Mar―18 Outbreak of Porcine Reproductive and Respiratory Syndrome Virus 1 in Taiwan Wei-Hao Lin, Kraijak Kaewprom, Sheng-Yuan Wang, Chuen-Fu Lin, Cheng-Yao Yang, Ming-Tang Chiou, Chao-Nan Lin
399 [GO] 2020―Feb―28 Acquisition of Avian-Origin PB1 Facilitates Viral RNA Synthesis by the 2009 Pandemic H1N1 Virus Polymerase Fangzheng Wang, Guanqun Liu, Yao Lu, Magda Hlasny, Qiang Liu, Yan Zhou
400 [GO] 2020―Feb―26 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies Syed Faraz Ahmed, Ahmed A. Q귮r, Matthew R. McKay
401 [GO] 2020―Feb―24 Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV Jiabao Xu, Shizhe Zhao, Tieshan Teng, Abualgasim Elgaili Abdalla, Wan Zhu, Longxiang Xie, et al. (+2)
402 [GO] 2020―Feb―19 Helicase of Type 2 Porcine Reproductive and Respiratory Syndrome Virus Strain HV Reveals a Unique Structure Chenjun Tang, Zengqin Deng, Xiaorong Li, Meiting Yang, Zizi Tian, Zhenhang Chen, et al. (+5)
403 [GO] 2020―Feb―11 Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections Schwartz
404 [GO] 2020―Feb―10 Antibody-Mediated Porcine Reproductive and Respiratory Syndrome Virus Infection Downregulates the Production of Interferon-α and Tumor Necrosis Factor-α in Porcine Alveolar Macrophages via Fc Gamma Receptor I and III Zhang
405 [GO] 2020―Feb―07 Genomic Characterization and Phylogenetic Classification of Bovine Coronaviruses Through Whole Genome Sequence Analysis Suzuki
406 [GO] 2020―Jan―24 Return of the Coronavirus: 2019-nCoV Lisa E. Gralinski, Vineet D. Menachery
407 [GO] 2020―Jan―22 Emerging Viruses without Borders: The Wuhan Coronavirus Shan-Lu Liu, Linda Saif
408 [GO] 2020―Jan―21 Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice Entao Li, Feihu Yan, Pei Huang, Hang Chi, Shengnan Xu, Guohua Li, et al. (+6)
409 [GO] 2020―Jan―10 A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses Javier A. Jaimes, Jean K. Millet, Alison E. Stout, Nicole M. André, Gary R. Whittaker
410 [GO] 2019―Dec―30 MYH9 Key Amino Acid Residues Identified by the Anti-Idiotypic Antibody to Porcine Reproductive and Respiratory Syndrome Virus Glycoprotein 5 Involve in the Virus Internalization by Porcine Alveolar Macrophages Liangliang Li, Lu Zhang, Qifan Hu, Liang Zhao, Yuchen Nan, Gaopeng Hou, et al. (+10)
411 [GO] 2019―Dec―20 Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Marc Desforges, Alain Le Coupanec, Philippe Dubeau, Andréanne Bourgouin, Louise Lajoie, Mathieu Dubé, Pierre J. Talbot
412 [GO] 2019―Dec―17 IFI16 Inhibits Porcine Reproductive and Respiratory Syndrome Virus 2 Replication in a MAVS-Dependent Manner in MARC-145 Cells Xiaobo Chang, Xibao Shi, Xiaozhuan Zhang, Li Wang, Xuewu Li, Aiping Wang, et al. (+3)
413 [GO] 2019―Dec―10 Fatty Acids Regulate Porcine Reproductive and Respiratory Syndrome Virus Infection via the AMPK-ACC1 Signaling Pathway Siwen Long, Yanrong Zhou, Dongcheng Bai, Wanjun Hao, Bohan Zheng, Shaobo Xiao, Liurong Fang
414 [GO] 2019―Dec―04 A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea Willman
415 [GO] 2019―Dec―02 Development and Validation of a S1 Protein-Based ELISA for the Specific Detection of Antibodies against Equine Coronavirus Shan Zhao, Constance Smits, Nancy Schuurman, Samantha Barnum, Nicola Pusterla, Frank van Kuppeveld, et al. (+3)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.119 sec